Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Sales | 5,239 | 5,286 | 5,418 | 7,159 | 5,738 |
| Cost of Goods | 4,082 | 4,560 | 5,771 | 7,310 | 5,793 |
| Gross Profit | 1,157 | 726 | -353 | -151 | -55 |
| Operating Expenses | 4,202 | 5,295 | 6,888 | 8,961 | 10,438 |
| Operating Income | -2,963 | -4,009 | -6,471 | -8,803 | -9,700 |
| Interest Expense | 217 | 36 | 75 | 93 | 312 |
| Other Income | 337 | 11 | 385 | 338 | 407 |
| Pre-tax Income | -2,842 | -4,034 | -6,161 | -8,558 | -9,605 |
| Net Income Continuous | -2,842 | -4,034 | -6,161 | -8,558 | -9,605 |
| Net Income | $-2,842 | $-4,034 | $-6,161 | $-8,558 | $-9,605 |
| EPS Basic Total Ops | -1.10 | -1.80 | -2.70 | -3.70 | -5.40 |
| EPS Basic Continuous Ops | -1.13 | -1.76 | -2.69 | -3.72 | -5.39 |
| EPS Diluted Total Ops | -1.10 | -1.80 | -2.70 | -3.70 | -5.40 |
| EPS Diluted Continuous Ops | -1.13 | -1.76 | -2.69 | -3.72 | -5.39 |
| EBITDA(a) | $-1,784 | $-2,960 | $-5,137 | $-7,705 | $-8,977 |